Laird Lab

The Laird Team studies the pathogenesis of movement disorders with a particular focus on identifying and testing potential disease treatments. Her group has been successful at producing and characterising the world’s first zebrafish model of spinocerebellar ataxia type-3 (also known as Machado Joseph Disease, MJD). They are currently testing the effect of various drugs on zebrafish models of spinocerebellar ataxia and amyotrophic lateral sclerosis (Lou Gehrig’s disease or motor neuron disease) with the aim of identifying a treatment for the disease.